| Title |
Cardiovascular Disease and Breast Cancer
|
|---|---|
| Published in |
Circulation, February 2018
|
| DOI | 10.1161/cir.0000000000000556 |
| Pubmed ID | |
| Authors |
Laxmi S Mehta, Karol E Watson, Ana Barac, Theresa M Beckie, Vera Bittner, Salvador Cruz-Flores, Susan Dent, Lavanya Kondapalli, Bonnie Ky, Tochukwu Okwuosa, Ileana L Piña, Annabelle Santos Volgman |
| Abstract |
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients. |
X Demographics
The data shown below were collected from the profiles of 237 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 46 | 19% |
| Spain | 23 | 10% |
| Venezuela, Bolivarian Republic of | 16 | 7% |
| Mexico | 14 | 6% |
| United Kingdom | 9 | 4% |
| Canada | 6 | 3% |
| Netherlands | 4 | 2% |
| France | 4 | 2% |
| Chile | 4 | 2% |
| Other | 21 | 9% |
| Unknown | 90 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 157 | 66% |
| Scientists | 37 | 16% |
| Practitioners (doctors, other healthcare professionals) | 35 | 15% |
| Science communicators (journalists, bloggers, editors) | 8 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 546 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 546 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 67 | 12% |
| Student > Ph. D. Student | 51 | 9% |
| Student > Master | 51 | 9% |
| Student > Bachelor | 51 | 9% |
| Other | 36 | 7% |
| Other | 109 | 20% |
| Unknown | 181 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 152 | 28% |
| Nursing and Health Professions | 39 | 7% |
| Biochemistry, Genetics and Molecular Biology | 30 | 5% |
| Agricultural and Biological Sciences | 22 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 3% |
| Other | 71 | 13% |
| Unknown | 214 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 764. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2023.
All research outputs
#25,944
of 25,728,350 outputs
Outputs from Circulation
#102
of 21,239 outputs
Outputs of similar age
#544
of 451,174 outputs
Outputs of similar age from Circulation
#4
of 186 outputs
Altmetric has tracked 25,728,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,239 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,174 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 186 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.